REFERENCES
- Schnachter J M, Aronson D C, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma. Cancer. 2002; 94: 1111–1120, [CSA]
- Pritchard J, Brown J, Shafford E A, et al. Preoperative chemotherapy with cisplatin and doxorubicin for childhood hepatoblastoma: results of the First Study of the International Society of Paediatric Oncology. J Clin Oncol. 2000; 18: 3819–3828, [PUBMED], [INFOTRIEVE], [CSA]
- Ortega J A, Krailo M D, Haas J E, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 1991; 2167–2176, [CSA]
- Saxena R, Leake J L, Shafford E A, et al. Chemotherapy effects on hepatoblastoma: a histological study. Am J Surg Pathol. 1993; 17: 1266–1271, [PUBMED], [INFOTRIEVE], [CSA]
- Quinn J T, Altman A J, Robinson H T, et al. Adriamycin and cisplatin for hepatoblastoma. Cancer 1985; 56: 1926–1929, [PUBMED], [INFOTRIEVE], [CSA]
- Yokomori K, Hori T, Asoh S, et al. Complete disappearance of unresectable hepatoblastoma by continuous infusion therapy through hepatic artery. J Pediatr Surg. 1991; 26: 844–846, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ortega J A, Douglass E C, Feusner J H, et al. Randomized comparison of cisplatin/vincristine/ fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from Children's Cancer Group and the Pedaitric Oncology Group. J Clin Oncol. 2000; 14: 2665–2675, [CSA]
- Perilongo G, Shafford E A, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma: final reprt of the second study of the International Society of Paediatric Oncology–SIOPEL 2. Eur J Cancer. 2004; 40: 411–421, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]